nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0294	0.0294	CcSEcCtD
Rivastigmine—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0242	CcSEcCtD
Rivastigmine—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0242	CcSEcCtD
Rivastigmine—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0235	0.0235	CcSEcCtD
Rivastigmine—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0213	0.0213	CcSEcCtD
Rivastigmine—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0167	CcSEcCtD
Rivastigmine—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0163	CcSEcCtD
Rivastigmine—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0155	CcSEcCtD
Rivastigmine—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0138	CcSEcCtD
Rivastigmine—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Rivastigmine—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0124	CcSEcCtD
Rivastigmine—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0121	CcSEcCtD
Rivastigmine—Gout—Hydrochlorothiazide—nephrolithiasis	0.012	0.012	CcSEcCtD
Rivastigmine—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Rivastigmine—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Rivastigmine—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Rivastigmine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Rivastigmine—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Rivastigmine—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Rivastigmine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00995	0.00995	CcSEcCtD
Rivastigmine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00938	0.00938	CcSEcCtD
Rivastigmine—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00933	0.00933	CcSEcCtD
Rivastigmine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00925	0.00925	CcSEcCtD
Rivastigmine—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00916	0.00916	CcSEcCtD
Rivastigmine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00908	0.00908	CcSEcCtD
Rivastigmine—Injury—Hydrochlorothiazide—nephrolithiasis	0.00883	0.00883	CcSEcCtD
Rivastigmine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00875	0.00875	CcSEcCtD
Rivastigmine—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00868	0.00868	CcSEcCtD
Rivastigmine—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00864	0.00864	CcSEcCtD
Rivastigmine—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0086	0.0086	CcSEcCtD
Rivastigmine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00857	0.00857	CcSEcCtD
Rivastigmine—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00853	0.00853	CcSEcCtD
Rivastigmine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00853	0.00853	CcSEcCtD
Rivastigmine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00842	0.00842	CcSEcCtD
Rivastigmine—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00835	0.00835	CcSEcCtD
Rivastigmine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00815	0.00815	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00812	0.00812	CcSEcCtD
Rivastigmine—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00812	0.00812	CcSEcCtD
Rivastigmine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00805	0.00805	CcSEcCtD
Rivastigmine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00799	0.00799	CcSEcCtD
Rivastigmine—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00799	0.00799	CcSEcCtD
Rivastigmine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00784	0.00784	CcSEcCtD
Rivastigmine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00769	0.00769	CcSEcCtD
Rivastigmine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00763	CcSEcCtD
Rivastigmine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0075	CcSEcCtD
Rivastigmine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00744	0.00744	CcSEcCtD
Rivastigmine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00741	0.00741	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00741	0.00741	CcSEcCtD
Rivastigmine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00739	0.00739	CcSEcCtD
Rivastigmine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00734	0.00734	CcSEcCtD
Rivastigmine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00731	0.00731	CcSEcCtD
Rivastigmine—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00718	CcSEcCtD
Rivastigmine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00716	0.00716	CcSEcCtD
Rivastigmine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00702	CcSEcCtD
Rivastigmine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00688	0.00688	CcSEcCtD
Rivastigmine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00683	0.00683	CcSEcCtD
Rivastigmine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00656	0.00656	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00652	0.00652	CcSEcCtD
Rivastigmine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00648	0.00648	CcSEcCtD
Rivastigmine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00646	0.00646	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0064	0.0064	CcSEcCtD
Rivastigmine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00639	0.00639	CcSEcCtD
Rivastigmine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00633	CcSEcCtD
Rivastigmine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00629	0.00629	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0062	0.0062	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00617	0.00617	CcSEcCtD
Rivastigmine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00615	0.00615	CcSEcCtD
Rivastigmine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00613	0.00613	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00613	0.00613	CcSEcCtD
Rivastigmine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00608	CcSEcCtD
Rivastigmine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00608	CcSEcCtD
Rivastigmine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.006	0.006	CcSEcCtD
Rivastigmine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00596	0.00596	CcSEcCtD
Rivastigmine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0059	CcSEcCtD
Rivastigmine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00587	CcSEcCtD
Rivastigmine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00572	0.00572	CcSEcCtD
Rivastigmine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00563	CcSEcCtD
Rivastigmine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00562	CcSEcCtD
Rivastigmine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00559	0.00559	CcSEcCtD
Rivastigmine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00557	0.00557	CcSEcCtD
Rivastigmine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00553	0.00553	CcSEcCtD
Rivastigmine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00541	CcSEcCtD
Rivastigmine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00531	CcSEcCtD
Rivastigmine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00524	CcSEcCtD
Rivastigmine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00521	CcSEcCtD
Rivastigmine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00502	0.00502	CcSEcCtD
Rivastigmine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00496	CcSEcCtD
Rivastigmine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00489	CcSEcCtD
Rivastigmine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00482	0.00482	CcSEcCtD
Rivastigmine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0048	0.0048	CcSEcCtD
Rivastigmine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00479	0.00479	CcSEcCtD
Rivastigmine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00475	CcSEcCtD
Rivastigmine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00473	CcSEcCtD
Rivastigmine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0047	0.0047	CcSEcCtD
Rivastigmine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00461	CcSEcCtD
Rivastigmine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00458	CcSEcCtD
Rivastigmine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00454	CcSEcCtD
Rivastigmine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00452	CcSEcCtD
Rivastigmine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00449	CcSEcCtD
Rivastigmine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00441	CcSEcCtD
Rivastigmine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00439	CcSEcCtD
Rivastigmine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00438	CcSEcCtD
Rivastigmine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00432	CcSEcCtD
Rivastigmine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0043	CcSEcCtD
Rivastigmine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00427	0.00427	CcSEcCtD
Rivastigmine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00416	CcSEcCtD
Rivastigmine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00416	CcSEcCtD
Rivastigmine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00416	CcSEcCtD
Rivastigmine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00415	CcSEcCtD
Rivastigmine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00411	CcSEcCtD
Rivastigmine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00407	CcSEcCtD
Rivastigmine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00402	CcSEcCtD
Rivastigmine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00399	CcSEcCtD
Rivastigmine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00393	0.00393	CcSEcCtD
Rivastigmine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00391	CcSEcCtD
Rivastigmine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00389	CcSEcCtD
Rivastigmine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00386	CcSEcCtD
Rivastigmine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0038	0.0038	CcSEcCtD
Rivastigmine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00373	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00364	CcSEcCtD
Rivastigmine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00361	CcSEcCtD
Rivastigmine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00358	CcSEcCtD
Rivastigmine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00356	0.00356	CcSEcCtD
Rivastigmine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00355	CcSEcCtD
Rivastigmine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00351	CcSEcCtD
Rivastigmine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00347	CcSEcCtD
Rivastigmine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00344	CcSEcCtD
Rivastigmine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00341	CcSEcCtD
Rivastigmine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00341	CcSEcCtD
Rivastigmine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00329	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00326	CcSEcCtD
Rivastigmine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00317	0.00317	CcSEcCtD
Rivastigmine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00315	CcSEcCtD
Rivastigmine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00315	CcSEcCtD
Rivastigmine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00294	CcSEcCtD
Rivastigmine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00286	CcSEcCtD
Rivastigmine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00282	CcSEcCtD
Rivastigmine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00273	CcSEcCtD
Rivastigmine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00264	CcSEcCtD
Rivastigmine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00254	CcSEcCtD
Rivastigmine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00252	CcSEcCtD
Rivastigmine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00251	CcSEcCtD
Rivastigmine—Headache—Hydrochlorothiazide—nephrolithiasis	0.0025	0.0025	CcSEcCtD
Rivastigmine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00237	CcSEcCtD
